Logo of Advanced Oxygen Therapy, Inc. - Oxygen Wound Therapy
  • Engaged Outcomes
  • Solutions
    • Topical Wound Oxygen (TWO2)
      • TWO2 Extremity Chamber
      • TWO2 Multi-Patch
    • NEXA™ NPWT System
    • Instructions for Use
      • USA
        • TWO2 – English
        • TWO2 Multi-Patch English
        • TWO2 – Spanish
        • NEXA System – English
      • International
        • TWO2
        • NEXA System
  • Clinicians
    • TWO2 Extremity Chamber
    • TWO2 Multi-Patch
    • Clinical Evidence
    • Educational Videos
    • Eyes on the Wound
    • FAQs
  • Patients
    • TWO2 Extremity Chamber
    • TWO2 Multi-Patch
    • NEXA™ NPWT System
    • Patient Education
    • TWO2 Testimonials
  • About
    • About Us
    • Partnerships
    • Management Team
    • Scientific Clinical Advisory Board
    • In the News
    • Events
    • Careers
    • Regulatory
  • Investors
    • Regulatory & Other News
    • Corporate Governance
    • Share Price Information
    • Financial Reports & Publications
    • Shareholders
    • Contacts and Advisors
    • Board of Directors
    • Email Alerts
    • AIM Rule 26
  • Contact Us

Guidelines for the use of topical oxygen therapy in the treatment of hard-to-heal wounds based on a Delphi consensus

by Mike Hughes | Jan 14, 2022

Guidelines for the use of topical oxygen therapy in the treatment of hard-to-heal wounds based on a Delphi consensus A growing body of evidence supports the use of topical oxygen therapy (TOT) in the treatment of diabetic foot ulcers (DFUs). Anecdotal evidence...
Topical Wound Oxygen Therapy in the Treatment of Severe Diabetic Foot Ulcers: A Prospective Controlled Study

Topical Wound Oxygen Therapy in the Treatment of Severe Diabetic Foot Ulcers: A Prospective Controlled Study

by Mike Hughes | Jan 14, 2022

Topical Wound Oxygen Therapy in the Treatment of Severe Diabetic Foot Ulcers: A Prospective Controlled Study Eric Blackman, MD, FRCS(C), FAADEP; Candice Moore, RN; John Hyatt, MD, FRCS(C); Richard Railton, MD, FRCS(C), FAGS; and Christian Frye, MD, MPH Abstract...
New Therapeutic Angiogenesis Biomakrers for Chronic Diabetic Foot Ulcers Treated with Transdermal Hyperoxia/Topical wound Oxygen (TWO2)

New Therapeutic Angiogenesis Biomakrers for Chronic Diabetic Foot Ulcers Treated with Transdermal Hyperoxia/Topical wound Oxygen (TWO2)

by Mike Hughes | Jan 14, 2022

New Therapeutic Angiogenesis Biomarkers for Chronic Diabetic Foot Ulcers Treated with Transdermal Hyperoxia/Topical Wound Oxygen (TWO2) Gary F. Scott, Ph.D. Department of Cell Biology and Genetics, University of North Texas Health Science Center, Fort Worth, Texas...
A Case Series Demonstrating the Use of Topical Wound Oxygen On Challenging Lower Extremity Wounds Presenting to A Community- Based Outpatient Clinic

A Case Series Demonstrating the Use of Topical Wound Oxygen On Challenging Lower Extremity Wounds Presenting to A Community- Based Outpatient Clinic

by Mike Hughes | Jan 14, 2022

A Case Series Demonstrating the Use of Topical Wound Oxygen On Challenging Lower Extremity Wounds Presenting to A Community-Based Outpatient Clinic. Lisa Horn-Stinson, DPM • Brian Skraba, BSN, RN • John Evans, LPN • Joliet Community-Based Outpatient Clinic, Joliet, IL...
Diabetic Neuroischemic Partial Thickness Burn: The Use of Topical Wound Oxygen with Human Amniotic Membrane 4 Weeks

Diabetic Neuroischemic Partial Thickness Burn: The Use of Topical Wound Oxygen with Human Amniotic Membrane 4 Weeks

by Mike Hughes | Jan 14, 2022

Multi-Modality Approach to Healing a Diabetic Neuroischemic Partial Thickness Burn: The Use of Topical Wound Oxygen with Human Amniotic Membrane Aliza Lee, DPM, MS, PGY-3; Paul Shearer, DPM Veterans Affairs Medical Center-Salem, VA Purpose To facilitate wound closure...
Page 11 of 13« First«...910111213»
  • Engaged Outcomes
  • Solutions
  • Clinical Evidence
  • About
  • Careers
  • Contact Us
  • Partnerships

ABOUT AOTI

We help people with chronic conditions get back to living their lives to the fullest by advancing health equity, access to care, and improving clinical outcomes and quality of life.

  • Follow
  • Follow
  • Follow
Let's Talk

MENU

  • Engaged Outcomes
  • Solutions
  • Clinical Evidence
  • About
  • Careers
  • Contact Us
  • Partnerships

Contact

1-866-HEAL-TWO

General Inquiries

customersupport@aotinc.net

Clinical Support

clinicalsupport@aotinc.net

Copyright ©2026, All Rights Reserved
MKT-100 Rev. G
  • Cookie Policy
  • Patents
  • Privacy Policy
  • SMS Texting Privacy Policy
  • Regulatory
  • Terms of Service

Copyright ©2026, All Rights Reserved

MKT-100 Rev. G

  • Cookie Policy
  • Patents
  • Privacy Policy
  • SMS Texting Privacy Policy
  • Regulatory
  • Terms of Service